China Medical Technologies, a Chinese medical device company that uses ultrasound technologies to treat solid cancers and tumors, filed for an initial public offering with the SEC on Friday night. The company plans to sell 5 million ADS's within a proposed price range of $14 to $16, which would result in an initial market cap of $375 million at the midpoint of the range. UBS Investment Bank is the sole underwriter on the deal. The company has filed to be traded on the NASDAQ under the ticker CMED.
